Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 19, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 11, subfamily B, polypeptide 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 11, subfamily B, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Neospora caninum | Os02g0824100 protein, related | Get druggable targets OG5_134469 | All targets in OG5_134469 |
Toxoplasma gondii | cytochrome p450 superfamily protein | Get druggable targets OG5_134469 | All targets in OG5_134469 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | cytochrome P450, family 19, subfamily A, polypeptide 1 | 503 aa | 425 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | Dual oxidase homolog | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Echinococcus multilocularis | peroxidasin | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.1048 | 1 | 0.5 |
Brugia malayi | Peroxidasin | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.1048 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | 0.1048 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | 0.1048 | 1 | 0.5 | |
Onchocerca volvulus | Peroxidasin homolog | 0.1048 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.1048 | 1 | 0.5 |
Schistosoma mansoni | peroxidasin | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Brugia malayi | Blistered cuticle protein 3 | 0.1048 | 1 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0922 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Echinococcus granulosus | peroxidasin | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | animal heme peroxidase | 0.1048 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1048 | 1 | 0.5 |
Onchocerca volvulus | 0.1048 | 1 | 0.5 | |
Schistosoma mansoni | peroxidasin | 0.1048 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.398 | Inhibition of aromatase | ChEMBL. | 20638757 |
IC50 (binding) | = 206 nM | In vitro inhibitory concentration against human CYP11B1 expressed in V79 MZh hamster fibroblasts incubated with 100 nM of substrate deoxycorticosterone in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 206 nM | In vitro inhibitory concentration against human CYP11B1 expressed in V79 MZh hamster fibroblasts incubated with 100 nM of substrate deoxycorticosterone in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 878 nM | In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxycorticosterone in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 878 nM | In vitro inhibitory concentration against human CYP11B2 expressed in V79MZh hamster fibroblasts incubated with 100 nM of substrate deoxycorticosterone in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 4000 nM | In vitro inhibitory concentration against human placental CYP19 incubated with 500 nM of substrate androstenedione in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 4000 nM | In vitro inhibitory concentration against human placental CYP19 incubated with 500 nM of substrate androstenedione in presence of the compound | ChEMBL. | 15743198 |
IC50 (binding) | = 4 uM | Inhibition of aromatase | ChEMBL. | 20638757 |
Inhibition (binding) | = 17 % | In vitro inhibition of human CYP17 expressed in Escherichia coli incubated with 2.5 uM of substrate progesterone in presence of 2.5 uM of compound | ChEMBL. | 15743198 |
Inhibition (binding) | = 17 % | In vitro inhibition of human CYP17 expressed in Escherichia coli incubated with 2.5 uM of substrate progesterone in presence of 2.5 uM of compound | ChEMBL. | 15743198 |
Inhibition (binding) | = 53 % | In vitro inhibition of human CYP11B2 expressed in Schizosaccharomyces pombe incubated with 100 nM of substrate deoxycorticosterone in presence of 500 nM of compound | ChEMBL. | 15743198 |
Inhibition (binding) | = 53 % | In vitro inhibition of human CYP11B2 expressed in Schizosaccharomyces pombe incubated with 100 nM of substrate deoxycorticosterone in presence of 500 nM of compound | ChEMBL. | 15743198 |
Selectivity ratio (binding) | = 0.2 | In vitro IC50 ratio of the compound against human CYP11B1 to that of human CYP11B2 | ChEMBL. | 15743198 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.